Terms: = Germ cell tumor AND ATM, TELO1, 472, ENSG00000149311, TEL1, ATD, ATE, DKFZp781A0353, AT1, Q13315, MGC74674, ATDC, ATC, ATA AND Staging
12 results:
1. Immune-Related Adverse Events After Immune Checkpoint Inhibitors for Melanoma Among Older Adults.
Schonfeld SJ; Tucker MA; Engels EA; Dores GM; Sampson JN; Shiels MS; Chanock SJ; Morton LM
JAMA Netw Open; 2022 Mar; 5(3):e223461. PubMed ID: 35315916
[TBL] [Abstract] [Full Text] [Related]
2. Multimodal imaging of thyroid cancer.
Brauckhoff K; Biermann M
Curr Opin Endocrinol Diabetes Obes; 2020 Oct; 27(5):335-344. PubMed ID: 32773568
[TBL] [Abstract] [Full Text] [Related]
3. Expression of BAP1 and atm proteins: Association with AJCC tumor category in uveal melanoma.
Jha J; Singh MK; Singh L; Pushker N; Bajaj MS; Sen S; Kashyap S
Ann Diagn Pathol; 2020 Feb; 44():151432. PubMed ID: 31864162
[TBL] [Abstract] [Full Text] [Related]
4. Validation of the 8th AJCC Cancer staging System for Pancreas Neuroendocrine tumors Using Korean Nationwide Surgery Database.
You Y; Jang JY; Kim SC; Yoon YS; Park JS; Cho CK; Park SJ; Yang JD; Lee WJ; Hong TH; Ahn KS; Jeong CY; Lee HK; Lee SE; Roh YH; Kim HJ; Kim H; Han IW
Cancer Res Treat; 2019 Oct; 51(4):1639-1652. PubMed ID: 30999719
[TBL] [Abstract] [Full Text] [Related]
5. Inter-observer variation in the histopathology reports of head and neck melanoma; a comparison between the seventh and eighth edition of the AJCC staging system.
Berger DMS; Wassenberg RM; Jóźwiak K; van de Wiel BA; Balm AJM; van den Berg JG; Klop WMC
Eur J Surg Oncol; 2019 Feb; 45(2):235-241. PubMed ID: 30385156
[TBL] [Abstract] [Full Text] [Related]
6. Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
Gershenwald JE; Scolyer RA; Hess KR; Sondak VK; Long GV; Ross MI; Lazar AJ; Faries MB; Kirkwood JM; McArthur GA; Haydu LE; Eggermont AMM; Flaherty KT; Balch CM; Thompson JF;
CA Cancer J Clin; 2017 Nov; 67(6):472-492. PubMed ID: 29028110
[TBL] [Abstract] [Full Text] [Related]
7. PROGNOSTIC VARIABLES AFFECTING PRIMARY TREatmENT OUTCOME FOR MEDULLARY THYROID CANCER.
Momin S; Chute D; Burkey B; Scharpf J
Endocr Pract; 2017 Sep; 23(9):1053-1058. PubMed ID: 28683235
[TBL] [Abstract] [Full Text] [Related]
8. Thyroid Cancer: Risk-Stratified Management and Individualized Therapy.
Raue F; Frank-Raue K
Clin Cancer Res; 2016 Oct; 22(20):5012-5021. PubMed ID: 27742787
[TBL] [Abstract] [Full Text] [Related]
9. Mesenteric tumor Deposits in Midgut Small Intestinal Neuroendocrine tumors Are a Stronger Indicator Than Lymph Node Metastasis for Liver Metastasis and Poor Prognosis.
Fata CR; Gonzalez RS; Liu E; Cates JM; Shi C
Am J Surg Pathol; 2017 Jan; 41(1):128-133. PubMed ID: 27684993
[TBL] [Abstract] [Full Text] [Related]
10. Serum levels of interleukin-1 receptor antagonist (IL-1ra) in thyroid cancer patients.
Niedźwiecki S; Stepień T; Kuzdak K; Stepień H; Krupiński R; Seehofer D; Rayes N; Ulrich F
Langenbecks Arch Surg; 2008 May; 393(3):275-80. PubMed ID: 18064485
[TBL] [Abstract] [Full Text] [Related]
11. Regional nodal metastatic disease is the strongest predictor of survival in patients with thin vertical growth phase melanomas: a case for SLN staging biopsy in these patients.
Karakousis GC; Gimotty PA; Czerniecki BJ; Elder DE; Elenitsas R; Ming ME; Fraker DL; Guerry D; Spitz FR
Ann Surg Oncol; 2007 May; 14(5):1596-603. PubMed ID: 17285396
[TBL] [Abstract] [Full Text] [Related]
12. Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor.
Ruggeri RM; Villari D; Simone A; Scarfi R; Attard M; Orlandi F; Barresi G; Trimarchi F; Trovato M; Benvenga S
J Endocrinol Invest; 2002 Dec; 25(11):959-66. PubMed ID: 12553555
[TBL] [Abstract] [Full Text] [Related]
